Successful Matched Unrelated BMT for Secondary AML Which Developed Simultaneously With Relapsed Hodgkin's Lymphoma

Bone Marrow Transplantation - United Kingdom
doi 10.1038/sj.bmt.1705642
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

PD-1 Blockade With Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma

New England Journal of Medicine
Medicine
2015English

Treatment of Refractory and Relapsed Hodgkin's Lymphoma: Facts and Perspectives

Haematologica
Hematology
2007English

Mocetinostat for Relapsed Classical Hodgkin's Lymphoma: An Open-Label, Single-Arm, Phase 2 Trial

The Lancet Oncology
Oncology
2011English

Successful Bridging Chemotherapy With Gemcitabine, Carboplatin, and Dexamethasone Before Unrelated Stem Cell Transplantation for Hepatosplenic T-Cell Lymphoma

Internal Medicine
Internal MedicineMedicine
2019English

Prognostic Value of Comorbidity for Auto-SCT Eligibility and Outcome in Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma

Bone Marrow Transplantation
TransplantationHematology
2010English

Haploidentical Hematopoietic Stem Cell Transplantation Compared With Hla-Matched Stem Cell Transplantation for Refractory or Relapsed Aggressive Non-Hodgkin Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Pulmonary Langerhans Cell Histiocytosis Associated With Hodgkin's Lymphoma

European Respiratory Review
PulmonaryRespiratory Medicine
2010English

VEGFandbFGFGene Polymorphisms in Patients With Non-Hodgkin's Lymphoma

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2013English

Evidence for a Cardiac Metabolic Switch in Patients With Hodgkin's Lymphoma

ESC heart failure
Cardiovascular MedicineCardiology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy